Financials
- Market Capitalization 45.01 M
- Employee 20
- Founded 1971
- CEO N/A
- Website www.verupharma.com
- Headquarter Wisconsin, United States
- FIGI BBG000G12J78
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.45
Relación precio/flujo de caja
12.31
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4297 | CNTX Context Therapeutics Inc. - Common Stock | 0.48 USD | -4.00% | -7.69% | -21.31% | -46.07% | 44.10 M USD | ||
| 4300 | MCRB Seres Therapeutics, Inc. - Common Stock | 4.56 USD | -0.22% | +0.22% | -8.43% | -44.59% | 45.33 M USD | ||
| 4310 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.96 USD | +7.69% | -2.97% | -73.69% | -79.67% | 44.46 M USD | ||
| 4315 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 6.75 USD | +5.97% | +2.43% | +48.03% | +625.81% | 43.95 M USD |